trending Market Intelligence /marketintelligence/en/news-insights/trending/zBYFnsjN9U47znVCl680kA2 content esgSubNav
In This List

Nephros to list on Nasdaq

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Nephros to list on Nasdaq

Nephros Inc.'s common shares have been approved to list on Nasdaq, one of the largest stock exchanges in the world.

The South Orange, N.J.-based company, which develops and sells liquid purification filters, is listed on the OTCQB Venture Market, a stock market for over-the-counter securities.

The company expects its common stock to begin trading on Nasdaq on Aug. 14 under its current ticker symbol NEPH.